Search Results
You are looking at 1 - 4 of 4 items for
- Author: Rodrigo A Toledo x
- Refine by access: All content x
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Yuejuan Qin in
Google Scholar
PubMed
Search for other papers by Subramanya Srikantan in
Google Scholar
PubMed
Search for other papers by Nicole Paes Morales in
Google Scholar
PubMed
Search for other papers by Qun Li in
Google Scholar
PubMed
Search for other papers by Yilun Deng in
Google Scholar
PubMed
Search for other papers by Sang-Woo Kim in
Google Scholar
PubMed
Search for other papers by Maria Adelaide A Pereira in
Google Scholar
PubMed
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
Search for other papers by Xiaoping Su in
Google Scholar
PubMed
Division of Hematology and Medical Oncology, Greehey Children Cancer Research Institute, University of São Paulo School of Medicine, Department of Bioinformatics and Computational Biology, Department of Medicine, Cancer Therapy and Research Center at the University of Texas Health Science Center, 7703 Floyd Curl Drive, MC 7880, San Antonio, Texas 78229-3900, USA
Search for other papers by Ricardo C T Aguiar in
Google Scholar
PubMed
Division of Hematology and Medical Oncology, Greehey Children Cancer Research Institute, University of São Paulo School of Medicine, Department of Bioinformatics and Computational Biology, Department of Medicine, Cancer Therapy and Research Center at the University of Texas Health Science Center, 7703 Floyd Curl Drive, MC 7880, San Antonio, Texas 78229-3900, USA
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Pheochromocytomas and paragangliomas are highly vascular tumors of the autonomic nervous system. Germline mutations, including those in hypoxia-related genes, occur in one third of the cases, but somatic mutations are infrequent in these tumors. Using exome sequencing of six paired constitutive and tumor DNA from sporadic pheochromocytomas and paragangliomas, we identified a somatic mutation in the HIF2A (EPAS1) gene. Screening of an additional 239 pheochromocytomas/paragangliomas uncovered three other HIF2A variants in sporadic (4/167, 2.3%) but not in hereditary tumors or controls. Three of the mutations involved proline 531, one of the two residues that controls HIF2α stability by hydroxylation. The fourth mutation, on Ser71, was adjacent to the DNA binding domain. No mutations were detected in the homologous regions of the HIF1A gene in 132 tumors. Mutant HIF2A tumors had increased expression of HIF2α target genes, suggesting an activating effect of the mutations. Ectopically expressed HIF2α mutants in HEK293, renal cell carcinoma 786-0, or rat pheochromocytoma PC12 cell lines showed increased stability, resistance to VHL-mediated degradation, target induction, and reduced chromaffin cell differentiation. Furthermore, mice injected with cells expressing mutant HIF2A developed tumors, and those with Pro531Thr and Pro531Ser mutations had shorter latency than tumors from mice with wild-type HIF2A. Our results support a direct oncogenic role for HIF2A in human neoplasia and strengthen the link between hypoxic pathways and pheochromocytomas and paragangliomas.
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Roxanne Hatakana in
Google Scholar
PubMed
Search for other papers by Delmar M Lourenço Jr in
Google Scholar
PubMed
Search for other papers by Susan C Lindsey in
Google Scholar
PubMed
Search for other papers by Cleber P Camacho in
Google Scholar
PubMed
Search for other papers by Marcio Almeida in
Google Scholar
PubMed
Search for other papers by José V Lima Jr in
Google Scholar
PubMed
Search for other papers by Tomoko Sekiya in
Google Scholar
PubMed
Search for other papers by Elena Garralda in
Google Scholar
PubMed
Search for other papers by Michel S Naslavsky in
Google Scholar
PubMed
Search for other papers by Guilherme L Yamamoto in
Google Scholar
PubMed
Search for other papers by Monize Lazar in
Google Scholar
PubMed
Search for other papers by Osorio Meirelles in
Google Scholar
PubMed
Search for other papers by Tiago J P Sobreira in
Google Scholar
PubMed
Search for other papers by Maria Lucia Lebrao in
Google Scholar
PubMed
Search for other papers by Yeda A O Duarte in
Google Scholar
PubMed
Search for other papers by John Blangero in
Google Scholar
PubMed
Search for other papers by Mayana Zatz in
Google Scholar
PubMed
Search for other papers by Janete M Cerutti in
Google Scholar
PubMed
Search for other papers by Rui M B Maciel in
Google Scholar
PubMed
Endocrine Genetics Unit (Laboratório de Investigação Médica/LIM-25) of Hospital das Clínicas, Nursing School, School of Public Health, Human Genome Research Center, Division of Genetics, Division of Endocrinology, Brazilian National Laboratory of Biosciences, Centro Integral Oncológico Clara Campal, Department of Genetics, Endocrinology Division, Laboratory of Epidemiology and Population Sciences, University of São Paulo School of Medicine, São Paulo, São Paulo 05403-010, Brazil
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
Accurate interpretation of germline mutations of the rearranged during transfection (RET) proto-oncogene is vital for the proper recommendation of preventive thyroidectomy in medullary thyroid carcinoma (MTC)-prone carriers. To gain information regarding the most disputed variant of RET, ATA-A Y791F, we sequenced blood DNA samples from a cohort of 2904 cancer-free elderly individuals (1261 via Sanger sequencing and 1643 via whole-exome/genome sequencing). We also accessed the exome sequences of an additional 8069 individuals from non-cancer-related laboratories and public databanks as well as genetic results from the Catalogue of Somatic Mutations in Cancer (COSMIC) project. The mean allelic frequency observed in the controls was 0.0031, with higher occurrences in Central European populations (0.006/0.008). The prevalence of RET Y791F in the control databases was extremely high compared with the 40 known RET pathogenic mutations (P=0.00003), while no somatic occurrence has been reported in tumours. In this study, we report new, unrelated Brazilian individuals with germline RET Y791F-only: two tumour-free elderly controls; two individuals with sporadic MTC whose Y791F-carrying relatives did not show any evidence of tumours; and a 74-year-old phaeochromocytoma patient without MTC. Furthermore, we showed that the co-occurrence of Y791F with the strong RET C634Y mutation explains the aggressive MTC phenotypes observed in a large affected family that was initially reported as Y791F-only. Our literature review revealed that limited analyses have led to the misclassification of RET Y791F as a probable pathogenic variant and, consequently, to the occurrence of unnecessary thyroidectomies. The current study will have a substantial clinical influence, as it reveals, in a comprehensive manner, that RET Y791F only shows no association with MTC susceptibility.
Search for other papers by Tomoko Sekiya in
Google Scholar
PubMed
Search for other papers by Marcello D Bronstein in
Google Scholar
PubMed
Search for other papers by Katiuscia Benfini in
Google Scholar
PubMed
Search for other papers by Viviane C Longuini in
Google Scholar
PubMed
Search for other papers by Raquel S Jallad in
Google Scholar
PubMed
Search for other papers by Marcio C Machado in
Google Scholar
PubMed
Search for other papers by Tatiana D Goncalves in
Google Scholar
PubMed
Search for other papers by Luciana H Osaki in
Google Scholar
PubMed
Search for other papers by Leonardo Higashi in
Google Scholar
PubMed
Endocrine Genetics Unit LIM-25, Neuroendocrinology Unit, Adrenal Unit (LIM-42), Experimental Oncology Laboratory (LIM-24), Nursing School, School of Public Health, Endocrinology Division, Brigadeiro Hospital, Federal University of Sao Paulo, Human Genome Research Center, Department of Cell and Developmental Biology, Instituto do Cérebro, National Institute of Aging, Institute of Pathology, School of Medicine, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil
Search for other papers by Jose Viana-Jr in
Google Scholar
PubMed
Search for other papers by Claudio Kater in
Google Scholar
PubMed
Search for other papers by Misu Lee in
Google Scholar
PubMed
Search for other papers by Sara Molatore in
Google Scholar
PubMed
Search for other papers by Guilherme Francisco in
Google Scholar
PubMed
Search for other papers by Roger Chammas in
Google Scholar
PubMed
Search for other papers by Michel S Naslavsky in
Google Scholar
PubMed
Endocrine Genetics Unit LIM-25, Neuroendocrinology Unit, Adrenal Unit (LIM-42), Experimental Oncology Laboratory (LIM-24), Nursing School, School of Public Health, Endocrinology Division, Brigadeiro Hospital, Federal University of Sao Paulo, Human Genome Research Center, Department of Cell and Developmental Biology, Instituto do Cérebro, National Institute of Aging, Institute of Pathology, School of Medicine, Hospital das Clinicas, University of Sao Paulo, Sao Paulo, Brazil
Search for other papers by David Schlesinger in
Google Scholar
PubMed
Search for other papers by Patricia Gama in
Google Scholar
PubMed
Search for other papers by Yeda A O Duarte in
Google Scholar
PubMed
Search for other papers by Maria Lucia Lebrão in
Google Scholar
PubMed
Search for other papers by Mayana Zatz in
Google Scholar
PubMed
Search for other papers by Osorio Meirelles in
Google Scholar
PubMed
Search for other papers by Bernardo Liberman in
Google Scholar
PubMed
Search for other papers by Maria Candida B V Fragoso in
Google Scholar
PubMed
Search for other papers by Sergio P A Toledo in
Google Scholar
PubMed
Search for other papers by Natalia S Pellegata in
Google Scholar
PubMed
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Abstract
Germline mutations in p27 kip1 are associated with increased susceptibility to multiple endocrine neoplasias (MEN) both in rats and humans; however, the potential role of common polymorphisms of this gene in endocrine tumor susceptibility and tumorigenesis remains mostly unrecognized. To assess the risk associated with polymorphism rs2066827 (p27-V109G), we genotyped a large cohort of Brazilian patients with sporadic endocrine tumors (pituitary adenomas, n=252; pheochromocytomas, n=125; medullary thyroid carcinoma, n=51; and parathyroid adenomas, n=19) and 885 population-matched healthy controls and determined the odds ratios and 95% CIs. Significant associations were found for the group of patients with pituitary adenomas (P=0.01), particularly for those with ACTH-secreting pituitary adenomas (P=0.005). In contrast, no association was found with GH-secreting pituitary tumors alone or with the sporadic counterpart of MEN2-component neoplasias. Our in vitro analyses revealed increased colony formation and cell growth rate for an AtT20 corticotropin mouse cell line overexpressing the p27-V109G variant compared with cells transfected with the WT p27. However, the genotypic effects in genetic and in vitro approaches were divergent. In accordance with our genetic data showing specificity for ACTH-secreting pituitary tissues, the overexpression of p27-V109G in a GH3 somatotropin rat cell line resulted in no difference compared with the WT. Pituitary tumors are one of the major clinical components of syndromes associated with the p27 pathogenic mutations MENX and MEN4. Our genetic and in vitro data indicate that the common polymorphism rs2066827 may play a role in corticotropinoma susceptibility and tumorigenesis through a molecular mechanism not fully understood thus far.
Search for other papers by Frederic Castinetti in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Search for other papers by Mariola Peczkowska in
Google Scholar
PubMed
Search for other papers by Marta Barontini in
Google Scholar
PubMed
Search for other papers by Kornelia Hasse-Lazar in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Rodrigo A Toledo in
Google Scholar
PubMed
Search for other papers by Sarka Dvorakova in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
Search for other papers by Maria Joao Bugalho in
Google Scholar
PubMed
Search for other papers by Stefania Zovato in
Google Scholar
PubMed
Search for other papers by Maria Alevizaki in
Google Scholar
PubMed
Search for other papers by Andrei Kvachenyuk in
Google Scholar
PubMed
Search for other papers by Birke Bausch in
Google Scholar
PubMed
Search for other papers by Paola Loli in
Google Scholar
PubMed
Search for other papers by Simona R Bergmann in
Google Scholar
PubMed
Search for other papers by Attila Patocs in
Google Scholar
PubMed
Search for other papers by Marija Pfeifer in
Google Scholar
PubMed
Search for other papers by Josefina Biarnes Costa in
Google Scholar
PubMed
Search for other papers by Ernst von Dobschuetz in
Google Scholar
PubMed
Search for other papers by Claudio Letizia in
Google Scholar
PubMed
Search for other papers by Gerlof Valk in
Google Scholar
PubMed
Search for other papers by Marcin Barczynski in
Google Scholar
PubMed
Search for other papers by Malgorzata Czetwertynska in
Google Scholar
PubMed
Search for other papers by John T M Plukker in
Google Scholar
PubMed
Search for other papers by Paola Sartorato in
Google Scholar
PubMed
Search for other papers by Tomas Zelinka in
Google Scholar
PubMed
Search for other papers by Petr Vlcek in
Google Scholar
PubMed
Search for other papers by Svetlana Yaremchuk in
Google Scholar
PubMed
Search for other papers by Georges Weryha in
Google Scholar
PubMed
Search for other papers by Letizia Canu in
Google Scholar
PubMed
Search for other papers by Nelson Wohllk in
Google Scholar
PubMed
Search for other papers by Frederic Sebag in
Google Scholar
PubMed
Search for other papers by Martin K Walz in
Google Scholar
PubMed
Search for other papers by Charis Eng in
Google Scholar
PubMed
Search for other papers by Hartmut P H Neumann in
Google Scholar
PubMed